Evaluation of novel data-driven metrics of amyloid β deposition for longitudinal PET studies
Purpose: Positron emission tomography (PET) provides in vivo quantification of amyloid-β (Aβ) pathology. Established methods for assessing Aβ burden can be affected by physiological and technical factors. Novel, data-driven metrics have been developed to account for these sources of variability. We...
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2023-10-01
|
| Series: | NeuroImage |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1053811923004640 |
| _version_ | 1797683188671184896 |
|---|---|
| author | Ariane Bollack Pawel J Markiewicz Alle Meije Wink Lloyd Prosser Johan Lilja Pierrick Bourgeat Jonathan M Schott William Coath Lyduine E Collij Hugh G Pemberton Gill Farrar Frederik Barkhof David M Cash |
| author_facet | Ariane Bollack Pawel J Markiewicz Alle Meije Wink Lloyd Prosser Johan Lilja Pierrick Bourgeat Jonathan M Schott William Coath Lyduine E Collij Hugh G Pemberton Gill Farrar Frederik Barkhof David M Cash |
| author_sort | Ariane Bollack |
| collection | DOAJ |
| description | Purpose: Positron emission tomography (PET) provides in vivo quantification of amyloid-β (Aβ) pathology. Established methods for assessing Aβ burden can be affected by physiological and technical factors. Novel, data-driven metrics have been developed to account for these sources of variability. We aimed to evaluate the performance of four of these amyloid PET metrics against conventional techniques, using a common set of criteria. Methods: Three cohorts were used for evaluation: Insight 46 (N=464, [18F]florbetapir), AIBL (N=277, [18F]flutemetamol), and an independent test-retest data (N=10, [18F]flutemetamol). Established metrics of amyloid tracer uptake included the Centiloid (CL) and where dynamic data was available, the non-displaceable binding potential (BPND). The four data-driven metrics computed were the amyloid load (Aβ load), the Aβ-PET pathology accumulation index (Aβ index), the Centiloid derived from non-negative matrix factorisation (CLNMF), and the amyloid pattern similarity score (AMPSS). These metrics were evaluated using reliability and repeatability in test-retest data, associations with BPND and CL, variability of the rate of change and sample size estimates to detect a 25% slowing in Aβ accumulation. Results: All metrics showed good reliability. Aβ load, Aβ index and CLNMF were strong associated with the BPND. The associations with CL suggest that cross-sectional measures of CLNMF, Aβ index and Aβ load are robust across studies. Sample size estimates for secondary prevention trial scenarios were the lowest for CLNMF and Aβ load compared to the CL. Conclusion: Among the novel data-driven metrics evaluated, the Aβ load, the Aβ index and the CLNMF can provide comparable performance to more established quantification methods of Aβ PET tracer uptake. The CLNMF and Aβ load could offer a more precise alternative to CL, although further studies in larger cohorts should be conducted. |
| first_indexed | 2024-03-12T00:10:55Z |
| format | Article |
| id | doaj.art-31a4b313a057412299854b162b868a65 |
| institution | Directory Open Access Journal |
| issn | 1095-9572 |
| language | English |
| last_indexed | 2024-03-12T00:10:55Z |
| publishDate | 2023-10-01 |
| publisher | Elsevier |
| record_format | Article |
| series | NeuroImage |
| spelling | doaj.art-31a4b313a057412299854b162b868a652023-09-16T05:28:55ZengElsevierNeuroImage1095-95722023-10-01280120313Evaluation of novel data-driven metrics of amyloid β deposition for longitudinal PET studiesAriane Bollack0Pawel J Markiewicz1Alle Meije Wink2Lloyd Prosser3Johan Lilja4Pierrick Bourgeat5Jonathan M Schott6William Coath7Lyduine E Collij8Hugh G Pemberton9Gill Farrar10Frederik Barkhof11David M Cash12Centre for Medical Image Computing, Department of Medical Physics and Biomedical Engineering, UCL, London, UK; Corresponding author.Centre for Medical Image Computing, Department of Medical Physics and Biomedical Engineering, UCL, London, UKAmsterdam UMC, location VUmc, Department of Radiology and Nuclear Medicine, Amsterdam, the NetherlandsDementia Research Centre, UCL Queen Square Institute of Neurology, London, UKHermes Medical Solutions, Stockholm, SwedenThe Australian e-Health Research Centre, CSIRO, Brisbane, AustraliaDementia Research Centre, UCL Queen Square Institute of Neurology, London, UKDementia Research Centre, UCL Queen Square Institute of Neurology, London, UKAmsterdam UMC, location VUmc, Department of Radiology and Nuclear Medicine, Amsterdam, the Netherlands; Clinical Memory Research Unit, Department of Clinical Sciences, Lund University, Malmö, SwedenCentre for Medical Image Computing, Department of Medical Physics and Biomedical Engineering, UCL, London, UK; GE HealthCare, Amersham, UK; Queen Square Institute of Neurology, University College London, UKGE HealthCare, Amersham, UKCentre for Medical Image Computing, Department of Medical Physics and Biomedical Engineering, UCL, London, UK; Amsterdam UMC, location VUmc, Department of Radiology and Nuclear Medicine, Amsterdam, the Netherlands; Queen Square Institute of Neurology, University College London, UKQueen Square Institute of Neurology, University College London, UK; UK Dementia Research Institute at University College London, London, UKPurpose: Positron emission tomography (PET) provides in vivo quantification of amyloid-β (Aβ) pathology. Established methods for assessing Aβ burden can be affected by physiological and technical factors. Novel, data-driven metrics have been developed to account for these sources of variability. We aimed to evaluate the performance of four of these amyloid PET metrics against conventional techniques, using a common set of criteria. Methods: Three cohorts were used for evaluation: Insight 46 (N=464, [18F]florbetapir), AIBL (N=277, [18F]flutemetamol), and an independent test-retest data (N=10, [18F]flutemetamol). Established metrics of amyloid tracer uptake included the Centiloid (CL) and where dynamic data was available, the non-displaceable binding potential (BPND). The four data-driven metrics computed were the amyloid load (Aβ load), the Aβ-PET pathology accumulation index (Aβ index), the Centiloid derived from non-negative matrix factorisation (CLNMF), and the amyloid pattern similarity score (AMPSS). These metrics were evaluated using reliability and repeatability in test-retest data, associations with BPND and CL, variability of the rate of change and sample size estimates to detect a 25% slowing in Aβ accumulation. Results: All metrics showed good reliability. Aβ load, Aβ index and CLNMF were strong associated with the BPND. The associations with CL suggest that cross-sectional measures of CLNMF, Aβ index and Aβ load are robust across studies. Sample size estimates for secondary prevention trial scenarios were the lowest for CLNMF and Aβ load compared to the CL. Conclusion: Among the novel data-driven metrics evaluated, the Aβ load, the Aβ index and the CLNMF can provide comparable performance to more established quantification methods of Aβ PET tracer uptake. The CLNMF and Aβ load could offer a more precise alternative to CL, although further studies in larger cohorts should be conducted.http://www.sciencedirect.com/science/article/pii/S1053811923004640QuantificationLongitudinalMachine learningAmyloidPETAlzheimer's |
| spellingShingle | Ariane Bollack Pawel J Markiewicz Alle Meije Wink Lloyd Prosser Johan Lilja Pierrick Bourgeat Jonathan M Schott William Coath Lyduine E Collij Hugh G Pemberton Gill Farrar Frederik Barkhof David M Cash Evaluation of novel data-driven metrics of amyloid β deposition for longitudinal PET studies NeuroImage Quantification Longitudinal Machine learning Amyloid PET Alzheimer's |
| title | Evaluation of novel data-driven metrics of amyloid β deposition for longitudinal PET studies |
| title_full | Evaluation of novel data-driven metrics of amyloid β deposition for longitudinal PET studies |
| title_fullStr | Evaluation of novel data-driven metrics of amyloid β deposition for longitudinal PET studies |
| title_full_unstemmed | Evaluation of novel data-driven metrics of amyloid β deposition for longitudinal PET studies |
| title_short | Evaluation of novel data-driven metrics of amyloid β deposition for longitudinal PET studies |
| title_sort | evaluation of novel data driven metrics of amyloid β deposition for longitudinal pet studies |
| topic | Quantification Longitudinal Machine learning Amyloid PET Alzheimer's |
| url | http://www.sciencedirect.com/science/article/pii/S1053811923004640 |
| work_keys_str_mv | AT arianebollack evaluationofnoveldatadrivenmetricsofamyloidbdepositionforlongitudinalpetstudies AT paweljmarkiewicz evaluationofnoveldatadrivenmetricsofamyloidbdepositionforlongitudinalpetstudies AT allemeijewink evaluationofnoveldatadrivenmetricsofamyloidbdepositionforlongitudinalpetstudies AT lloydprosser evaluationofnoveldatadrivenmetricsofamyloidbdepositionforlongitudinalpetstudies AT johanlilja evaluationofnoveldatadrivenmetricsofamyloidbdepositionforlongitudinalpetstudies AT pierrickbourgeat evaluationofnoveldatadrivenmetricsofamyloidbdepositionforlongitudinalpetstudies AT jonathanmschott evaluationofnoveldatadrivenmetricsofamyloidbdepositionforlongitudinalpetstudies AT williamcoath evaluationofnoveldatadrivenmetricsofamyloidbdepositionforlongitudinalpetstudies AT lyduineecollij evaluationofnoveldatadrivenmetricsofamyloidbdepositionforlongitudinalpetstudies AT hughgpemberton evaluationofnoveldatadrivenmetricsofamyloidbdepositionforlongitudinalpetstudies AT gillfarrar evaluationofnoveldatadrivenmetricsofamyloidbdepositionforlongitudinalpetstudies AT frederikbarkhof evaluationofnoveldatadrivenmetricsofamyloidbdepositionforlongitudinalpetstudies AT davidmcash evaluationofnoveldatadrivenmetricsofamyloidbdepositionforlongitudinalpetstudies |